New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 1, 2013
08:29 EDTVVUSVIVUS: Study finds weight loss with Qsymia improves cardiovascular risk factors
VIVUS announced the publication of a study concluding that weight loss resulting from treatment with Qsymia capsules CIV led to significant improvements in cholesterol, blood pressure and triglycerides in obese and overweight patients experiencing one or more of these associated conditions. The improvements were significantly greater among patients who lost 10% or more of their starting weight, the company said. The study was published online in The American Journal of Cardiology.
News For VVUS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 15, 2015
19:34 EDTVVUSVIVUS files patent infringement lawsuit against Teva
Subscribe for More Information
April 14, 2015
07:10 EDTVVUSVIVUS says CVOT 'unlikely to initiate' in 2015
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use